• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Micardis (telmisartan) and Micardis HCT (telmisartan/hydrochlorothiazide) tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – October 2012

Summary View

 

CONTRAINDICATIONS

  • Do not co-administer aliskiren with Micardis HCT in patients with diabetes
 

PRECAUTIONS

Drug Interactions
  • Aliskiren: Do not co-administer aliskiren with Micardis /HCT in patients with diabetes. Avoid use of aliskiren with Micardis/HCT in patients with renal impairment (GFR <60 ml/min).